%0 Journal Article
%T Prevalence of Dyslipidemia among Patients Received at the Biochemistry Unit of the Charles de Gaulle Pediatric University Hospital in Ouagadougou
%A Fabienne Marie Soudre
%A Arnaud Kouraogo
%A Alice Kiba
%A Ollo Da
%A Mahutin Beno£¿te Hounhoui
%A Diema Nadia Karama
%A Seraphine Mano
%A Denis Claude Drabo
%A Augustin Kyetega
%A Raoul Karfo
%A Elie Kabre
%A Jean Sakande
%J Advances in Biological Chemistry
%P 16-26
%@ 2162-2191
%D 2024
%I Scientific Research Publishing
%R 10.4236/abc.2024.141002
%X <strong>Introduction:</strong> Cardiovascular disease represents a major public health burden worldwide. Research and management of risk factors contribute to the prevention of these diseases. The aim of this study was to assess the prevalence of dyslipidemia in the biochemistry unit of the Charles De Gaulle Pediatric University Hospital (CHUP-CDG) in Ouagadougou. <strong>Material and Methods:</strong> This was a descriptive and analytical cross-sectional study, with retrospective data collection from January 1, 2020 to December 31, 2022. Patients of all ages who performed a lipid panel in the CHUP-CDG biochemistry unit during the study period have been included. <strong>Results:</strong> A total of 2872 patients have been included. The mean age of the study population was 27.72 ¡À 19.51 years and the M/F sex ratio was 0.81. Among the patients, 22.84% had at least one dyslipidemia. The prevalences of hypercholesterolemia, hypo-HDL cholesterolemia and hyper-LDL cholesterolemia were 11.57%, 49.19% and 57.50% respectively. Hypertriglyceridemia and mixed hyperlipidemia were present in 9.04% and 2.08% of patients. Hypercholesterolemia was significantly more frequent in the female sex (p = 0.0077); hyper-LDL cholesterolemia (p = 0.0255) and mixed hyperlipidemia (p &lt; 0.00001) in patients over 45 years of age. <strong>Conclusion: </strong>The relatively high prevalence of dyslipidemia in the study indicates a worrying situation. It would therefore appear essential to extend the search for risk factors nationwide, particularly those that can be modified, in order to reduce morbidity and mortality linked to cardiovascular disease.
%K Dyslipidemia
%K Lipid Profile
%K Lipid Abnormalities
%K Prevalence
%K Burkina Faso
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=131115